Cellife NAD II

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

ferrous fumarate, Quantity: 25 mg (Equivalent: iron, Qty 8 mg); nicotinamide, Quantity: 10 mg; manganese amino acid chelate, Quantity: 35 mg (Equivalent: manganese, Qty 3.5 mg); cyanocobalamin, Quantity: 0.0024 mg; leucine, Quantity: 100 mg; heavy magnesium oxide, Quantity: 100 mg (Equivalent: magnesium, Qty 60 mg); nicotinic acid, Quantity: 100 mg; calcium gluconate monohydrate, Quantity: 225 mg (Equivalent: calcium, Qty 20 mg); quercetin, Quantity: 13 mg; menaquinone 7, Quantity: 0.06 mg; Cinnamomum cassia, Quantity: 50 mg (Equivalent: Cinnamomum cassia, Qty 500 mg; Equivalent: coumarin, Qty 0.001 mg); Reynoutria japonica, Quantity: 30 mg (Equivalent: Reynoutria japonica, Qty 300 mg); zinc glycinate, Quantity: 29 mg (Equivalent: zinc, Qty 8 mg)

제공처:

Cellife Health Products Pty Ltd

약제 형태:

Tablet, uncoated

구성:

Excipient Ingredients: microcrystalline cellulose; isomalt; magnesium stearate; colloidal anhydrous silica; mannitol

관리 경로:

Oral

치료 징후:

Helps reduce/decrease free radical damage to body cells ; Helps improve/promote body metabolism/metabolic rate ; Maintain/support body tissue repair/regeneration

제품 요약:

Visual Identification: ;

승인 상태:

Listed

승인 날짜:

2019-08-21